Abstract

The N-terminal regulatory region of the high affinity cAMP-specific phosphodiesterase, PDE7A1, contains two copies of the cAMP-dependent kinase (PKA) pseudosubstrate site RRGAI. In betaTC3 insulinoma cells, PDE7A1 co-localizes with PKA II in the Golgi-centrosome region. The roles PDE7A1 and its regulatory region play in cAMP signaling were examined by studying interactions with PKA subunits. PDE7A1 associates with the dissociated C subunit of PKA (C), but does not bind tetrameric PKA holoenzyme. High affinity binding of C by PDE7A1 inhibits kinase activity in vitro (IC50 = 0.5 nm). The domain containing PKA pseudosubstrate sites at the N terminus of PDE7A1 mediates complex formation with C. The PDE7A1 N-terminal repeat region inhibits C activity in CHO-K1 cells and also suppresses C dependent, cAMP-independent, physiological responses in yeast. Thus, PDE7A1 possesses a non-catalytic activity that can contribute to the termination of cAMP signals via direct inhibition of C. This study identifies a novel inhibitor of PKA and a non-catalytic affect of a cyclic nucleotide phosphodiesterase.

Highlights

  • Cyclic AMP is a second messenger that mediates diverse cellular responses to hormones and neurotransmitters

  • Cyclic AMP-independent Suppression of Yeast C Phenotypes by PDE7A1—To further assess whether PDE7A1 can inhibit C signaling in vivo via pseudosubstrate site-mediated interaction, we examined the effects of PDE7A1 on C-dependent phenotypes in yeast that are independent of cAMP levels

  • We identified a non-catalytic activity of PDE7A1 that can contribute to the termination of cAMP signals

Read more

Summary

Introduction

Cyclic AMP (cAMP) is a second messenger that mediates diverse cellular responses to hormones and neurotransmitters. The N-terminal regulatory region of the high affinity cAMP-specific phosphodiesterase, PDE7A1, contains two copies of the cAMPdependent kinase (PKA) pseudosubstrate site RRGAI. The presence of PKA pseudosubstrate sites in PDE7A1 N terminus raises the possibility that, like PKI and PKA regulatory subunits, PDE7A1 can limit cAMP signaling by binding and inhibiting C.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call